Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
top of page
BPIQ Blog
Sep 1, 20223 min read
ESMO 2022 Investor Hub
Updated 9/6/22 Summary The Euorpean Society for Medical Oncology (ESMO) takes place from Sept 9-13, 2022 in Paris ESMO is "the most...
Aug 15, 20221 min read
Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Free Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Aug 15, 20221 min read
Free Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Dec 31, 20212 min read
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page